Holen Sie sich die Stockscreener-App
27.98
0.36%
0.10
Schlusskurs vom Vortag:
$27.88
Offen:
$28.2
24-Stunden-Volumen:
255.61K
Relative Volume:
0.77
Marktkapitalisierung:
$1.25B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.24%
1M Leistung:
+6.92%
6M Leistung:
+145.44%
1J Leistung:
+31.05%
1-Tages-Spanne:
$27.72
$29.00
1-Wochen-Bereich:
$27.50
$29.23
52-Wochen-Spanne:
$4.17
$30.50
Septerna Inc Stock (SEPN) Company Profile
Firmenname
Septerna Inc
Sektor
Branche
Telefon
650-338-3533
Adresse
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Vergleichen Sie SEPN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
27.98 | 1.25B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | Raymond James | Strong Buy |
| 2025-12-15 | Eingeleitet | Truist | Buy |
| 2025-11-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-02-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-19 | Eingeleitet | TD Cowen | Buy |
| 2024-11-19 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Septerna Inc Aktie (SEPN) Neueste Nachrichten
What analysts say about Septerna Inc stockDividend Yield Trends & AI-Based Predictions Available Free - earlytimes.in
Jones Trading initiates coverage of Septerna (SEPN) with buy recommendation - MSN
Jones Trading Initiates Coverage of Septerna (SEPN) with Buy Recommendation - Nasdaq
Septerna stock initiated with Buy rating at Jones Trading on GPCR pipeline By Investing.com - Investing.com South Africa
Septerna stock initiated with Buy rating at Jones Trading on GPCR pipeline - Investing.com Nigeria
Septerna (NASDAQ:SEPN) Coverage Initiated at Jones Trading - MarketBeat
Septerna (SEPN): Valuation Check After Raymond James Buy Rating and S&P Pharma Index Inclusion - Sahm
Septerna, Inc.(NasdaqGM: SEPN) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Septerna, Inc.(NasdaqGM: SEPN) added to NASDAQ Biotechnology Index - marketscreener.com
Septerna’s SEP-631 Study: A Potential Game-Changer in Pharmaceutical Research - MSN
Is New Coverage of Septerna (SEPN) Quietly Reframing Its GPCR Platform’s Risk‑Reward Profile? - simplywall.st
Septerna (NASDAQ:SEPN) Coverage Initiated at Raymond James Financial - Defense World
Septerna (NASDAQ:SEPN) Raised to "Strong-Buy" at Raymond James Financial - MarketBeat
Wall Street Zen Upgrades Septerna (NASDAQ:SEPN) to "Strong-Buy" - MarketBeat
Wall Street Zen Upgrades Septerna (NASDAQ:SEPN) to “Strong-Buy” - Defense World
Why Septerna Inc. stock could be next big winner2025 AllTime Highs & Risk Controlled Stock Pick Alerts - Улправда
Septerna Inc stock hits all-time high at 29.79 USD By Investing.com - Investing.com Nigeria
Septerna (NASDAQ:SEPN) Reaches New 12-Month HighShould You Buy? - MarketBeat
Septerna Inc stock hits all-time high at 29.79 USD - Investing.com
Raymond James Initiates Coverage of Septerna (SEPN) with Strong Buy Recommendation - Nasdaq
Raymond James initiates Septerna stock with Strong Buy rating, $38 target - Investing.com Australia
Raymond James Initiates Coverage on Septerna With Strong Buy Rating, $38 Price Target - marketscreener.com
Raymond James initiates Septerna stock with Strong Buy rating, $38 target By Investing.com - Investing.com India
Why Septerna Inc. stock is a must watch in 20252025 Sector Review & Risk Managed Investment Strategies - DonanımHaber
How institutional buying supports Septerna Inc. stockWeekly Earnings Recap & Daily Price Action Insights - Улправда
How Septerna Inc. stock benefits from tech adoptionInsider Selling & Long-Term Investment Growth Plans - Улправда
Septerna (NASDAQ:SEPN) Earns Buy Rating from Analysts at Truist Financial - Defense World
Septerna, Inc. (NASDAQ:SEPN) Receives $29.25 Average Target Price from Brokerages - Defense World
Septerna (NASDAQ:SEPN) Coverage Initiated at Truist Financial - MarketBeat
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
PRN_FinancialWrapper | PR NewswireSepterna to Present at 44th Annual J.P. Morgan Healthcare Conference - FinancialContent
Septerna initiated with a buy at Truist - MSN
Septerna (NASDAQ:SEPN) Trading Up 6.7%Here's Why - MarketBeat
Septerna (SEPN) Receives New "Buy" Rating and $34 Price Target f - GuruFocus
Septerna, Inc. (NASDAQ:SEPN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Truist Securities initiates Septerna stock with Buy rating on novel drug pipeline By Investing.com - Investing.com South Africa
Truist Securities initiates Septerna stock with Buy rating on novel drug pipeline - Investing.com India
Truist Initiates Septerna at Buy With $34 Price Target - marketscreener.com
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - MSN
Will Septerna Inc. stock continue dividend increasesJuly 2025 Fed Impact & Smart Money Movement Tracker - Newser
Septerna, Inc. $SEPN Shares Sold by Sio Capital Management LLC - MarketBeat
What hedge fund activity signals for Septerna Inc. stockPortfolio Return Summary & Low Drawdown Momentum Ideas - Newser
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled - MSN
Septerna (SEPN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Septerna Inc. stock beat market expectations this quarterQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser
Finanzdaten der Septerna Inc-Aktie (SEPN)
Es liegen keine Finanzdaten für Septerna Inc (SEPN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):